" /> Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 - CISMeF





Preferred Label : Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961;

NCIt synonyms : Autologous Anti-NY-ESO-1 TCR/CD8a-expressing T-cells GSK3901961;

NCIt definition : A preparation of human autologous T-lymphocytes that are genetically modified to express a T-cell receptor (TCR) specific for the human cancer-testis antigen NY-ESO-1 and the CD8alpha co-receptor, with potential immunostimulating and antineoplastic activities. Upon leukapheresis, isolation, transduction, expansion ex vivo, and reintroduction into the patient, the autologous anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 recognize and bind to NY-ESO-1-overexpressing tumor cells. This may result in a specific cytotoxic T-lymphocyte (CTL)-mediated killing of NY-ESO-1-positive tumor cells. NY-ESO-1, a tumor-associated antigen (TAA), is found in normal testis and on the surface of various tumor cell types. Co-expression of CD8alpha may broaden the immune response against tumors and increase antitumor activity by converting CD4 helper T-cells into CD8 cytotoxic T-cells.;

Molecule name : GSK 3901961; GSK-3901961;

NCI Metathesaurus CUI : CL1413471;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.